1. Home
  2. ECO vs AMPH Comparison

ECO vs AMPH Comparison

Compare ECO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okeanis Eco Tankers Corp.

ECO

Okeanis Eco Tankers Corp.

HOLD

Current Price

$39.04

Market Cap

1.1B

Sector

N/A

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECO
AMPH
Founded
2018
1996
Country
Greece
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ECO
AMPH
Price
$39.04
$26.02
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$37.00
$31.00
AVG Volume (30 Days)
318.3K
360.6K
Earning Date
02-18-2026
02-26-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
2.38
2.27
Revenue
$349,886,578.00
$723,305,000.00
Revenue This Year
N/A
$1.35
Revenue Next Year
$5.10
$5.10
P/E Ratio
$18.83
$12.23
Revenue Growth
N/A
N/A
52 Week Low
$17.91
$20.39
52 Week High
$41.31
$39.01

Technical Indicators

Market Signals
Indicator
ECO
AMPH
Relative Strength Index (RSI) 62.60 44.32
Support Level $31.75 $27.31
Resistance Level $41.31 $29.52
Average True Range (ATR) 1.10 1.05
MACD 0.73 -0.01
Stochastic Oscillator 76.34 4.53

Price Performance

Historical Comparison
ECO
AMPH

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: